NCT06888804 Posterior Tibial Nerve PRF for Painful Calcaneal Fracture
| NCT ID | NCT06888804 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Diskapi Teaching and Research Hospital |
| Condition | Calcaneus Fracture |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-03-17 |
| Primary Completion | 2025-09-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2025-03-17 with a primary completion date of 2025-09-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Patients who underwent pulsed radiofrequency (PRF) treatment of the posterior tibial nerve under ultrasound guidance, which is routinely performed in our clinic for severe heel pain following a calcaneal fracture, were evaluated through interviews. The assessment was conducted using the Visual Analog Scale (VAS) for pain and the American Orthopaedic Foot and Ankle Society (AOFAS) score.
Eligibility Criteria
Inclusion Criteria: * History of calcaneal fracture * VAS score \>5 * Pain persisting for more than 3 months after the fracture Exclusion Criteria: * Presence of other foot pain-causing conditions (e.g., plantar fasciitis, heel spur) * Additional fractures other than the calcaneus * Pregnancy * Coagulopathy or use of antiplatelet medications * Mental illness impairing decision-making ability
Contact & Investigator
Gevher Rabia Genc Perdecioğlu
STUDY CHAIR
Diskapi TRH
Frequently Asked Questions
Who can join the NCT06888804 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Calcaneus Fracture. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06888804 currently recruiting?
Yes, NCT06888804 is actively recruiting participants. Contact the research team at gkoyldz@gmail.com for enrollment information.
Where is the NCT06888804 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT06888804 clinical trial?
NCT06888804 is sponsored by Diskapi Teaching and Research Hospital. The principal investigator is Gevher Rabia Genc Perdecioğlu at Diskapi TRH. The trial plans to enroll 50 participants.